Celyad Oncology S.A.
CYAD · NASDAQ
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | -$3,044 | -$4,708 | -$3,740 |
| Dep. & Amort. | – | $229 | $397 | $397 |
| Deferred Tax | – | $0 | $0 | -$1,238 |
| Stock-Based Comp. | – | $6 | $491 | $444 |
| Change in WC | – | $306 | $2,394 | -$3,599 |
| Other Non-Cash | – | -$328 | -$5,445 | -$595 |
| Operating Cash Flow | – | -$2,831 | -$6,871 | -$8,331 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | $0 | -$583 | -$350 |
| Net Acquisitions | – | $0 | $26 | $1,315 |
| Inv. Purchases | – | $0 | $0 | $0 |
| Inv. Sales/Matur. | – | $0 | $0 | $0 |
| Other Inv. Act. | – | -$118 | $25 | $1,281 |
| Investing Cash Flow | – | -$118 | -$558 | $965 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | -$83 | $0 | -$92 |
| Stock Issued | – | $0 | $9,490 | $0 |
| Stock Repurch. | – | $0 | $10 | -$10 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | $2,258 | $9,457 | $0 |
| Financing Cash Flow | – | $2,175 | $9,457 | -$102 |
| Forex Effect | – | $0 | $0 | -$1 |
| Net Chg. in Cash | – | $6,229 | $2,028 | -$7,469 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $0 | $4,976 | $12,445 |
| End Cash | – | $6,229 | $7,004 | $4,976 |
| Free Cash Flow | – | -$2,831 | -$7,454 | -$8,681 |